Li N. Komatsu

Array ( [id] => 6575100 [patent_doc_number] => 20100273721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/792393 [patent_app_country] => US [patent_app_date] => 2010-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14831 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273721.pdf [firstpage_image] =>[orig_patent_app_number] => 12792393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160140 [patent_doc_number] => 20120101039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'CALCIUM-SENSING RECEPTOR-ACTIVE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/322189 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20815 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20120101039.pdf [firstpage_image] =>[orig_patent_app_number] => 13322189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8253090 [patent_doc_number] => 20120157394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'SELECTIVE CASPASE INHIBITORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/321681 [patent_app_country] => US [patent_app_date] => 2010-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 50004 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20120157394.pdf [firstpage_image] =>[orig_patent_app_number] => 13321681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6391650 [patent_doc_number] => 20100303783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'Methods of Treating Urogenital-Neurological Disorders Using Tachykinin Retargeted Endopepidases' [patent_app_type] => utility [patent_app_number] => 12/781099 [patent_app_country] => US [patent_app_date] => 2010-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 52532 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303783.pdf [firstpage_image] =>[orig_patent_app_number] => 12781099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6391751 [patent_doc_number] => 20100303794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'Methods of Treating Urogenital-Neurological Disorders Using Glucagon Like Hormone Retargeted Endopepidases' [patent_app_type] => utility [patent_app_number] => 12/781126 [patent_app_country] => US [patent_app_date] => 2010-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 55772 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303794.pdf [firstpage_image] =>[orig_patent_app_number] => 12781126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6391727 [patent_doc_number] => 20100303791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'Methods of Treating Chronic Neurogenic Inflammation Using Glucagon Like Hormone Retargeted Endopepidases' [patent_app_type] => utility [patent_app_number] => 12/781284 [patent_app_country] => US [patent_app_date] => 2010-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 47199 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303791.pdf [firstpage_image] =>[orig_patent_app_number] => 12781284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6391782 [patent_doc_number] => 20100303798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'Methods of Treating Urogenital-Neurological Disorders Using Neurotrophin Retargeted Endopepidases' [patent_app_type] => utility [patent_app_number] => 12/781113 [patent_app_country] => US [patent_app_date] => 2010-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 54462 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303798.pdf [firstpage_image] =>[orig_patent_app_number] => 12781113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6391707 [patent_doc_number] => 20100303789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'Methods of Treating Chronic Neurogenic Inflammation Using Neurotrophin Retargeted Endopepidases' [patent_app_type] => utility [patent_app_number] => 12/781261 [patent_app_country] => US [patent_app_date] => 2010-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 46059 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303789.pdf [firstpage_image] =>[orig_patent_app_number] => 12781261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6391698 [patent_doc_number] => 20100303788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'Methods of Treating Chronic Neurogenic Inflammation Using Galanin Retargeted Endopepidases' [patent_app_type] => utility [patent_app_number] => 12/781216 [patent_app_country] => US [patent_app_date] => 2010-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 46062 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303788.pdf [firstpage_image] =>[orig_patent_app_number] => 12781216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8621584 [patent_doc_number] => 08354499 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-15 [patent_title] => 'Cyanine-based probe\\tag-peptide pair fluorescence protein imaging and fluorescence protein imaging methods' [patent_app_type] => utility [patent_app_number] => 12/773707 [patent_app_country] => US [patent_app_date] => 2010-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 4866 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12773707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8220862 [patent_doc_number] => 20120135070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'Copolymers' [patent_app_type] => utility [patent_app_number] => 13/266732 [patent_app_country] => US [patent_app_date] => 2010-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10676 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13266732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9059900 [patent_doc_number] => 08546335 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Peptidic hydrolyzate proteasome activators and compositions containing same' [patent_app_type] => utility [patent_app_number] => 13/265045 [patent_app_country] => US [patent_app_date] => 2010-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 7332 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13265045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545420 [patent_doc_number] => 20100222250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'POLY-BETA-PEPTIDES FROM FUNCTIONALIZED BETA-LACTAM MONOMERS AND ANTIBACTERIAL COMPOSITIONS CONTAINING SAME' [patent_app_type] => utility [patent_app_number] => 12/759998 [patent_app_country] => US [patent_app_date] => 2010-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11634 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222250.pdf [firstpage_image] =>[orig_patent_app_number] => 12759998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8768033 [patent_doc_number] => 20130096070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'PEPTIDE TARGETING OF INNER EAR CELLS' [patent_app_type] => utility [patent_app_number] => 13/263719 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10886 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13263719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10533410 [patent_doc_number] => 09259023 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => 'Process for making a milk-based protein hydrolysate' [patent_app_type] => utility [patent_app_number] => 12/752207 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10805 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12752207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9350336 [patent_doc_number] => 08669227 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-11 [patent_title] => 'Fast-acting insulin formulation' [patent_app_type] => utility [patent_app_number] => 12/662036 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5308 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 222 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12662036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11479657 [patent_doc_number] => 09586180 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-07 [patent_title] => 'Membrane evaporation for generating highly concentrated protein therapeutics' [patent_app_type] => utility [patent_app_number] => 13/259341 [patent_app_country] => US [patent_app_date] => 2010-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11485 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13259341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8128339 [patent_doc_number] => 20120088718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'HCV-DERIVED POLYPEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/256786 [patent_app_country] => US [patent_app_date] => 2010-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15615 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20120088718.pdf [firstpage_image] =>[orig_patent_app_number] => 13256786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7791573 [patent_doc_number] => 20120053129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'TARGET-ACTIVATED CELL/TISSUE-PENETRATING PEPTIDE FOR DELIVERY OF IMPERMEABLE COMPOUNDS AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/202317 [patent_app_country] => US [patent_app_date] => 2010-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5217 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053129.pdf [firstpage_image] =>[orig_patent_app_number] => 13202317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817400 [patent_doc_number] => 20120064020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'NOVEL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/201996 [patent_app_country] => US [patent_app_date] => 2010-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7521 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064020.pdf [firstpage_image] =>[orig_patent_app_number] => 13201996 [rel_patent_id] =>[rel_patent_doc_number] =>)